| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8313444 | Clinica Chimica Acta | 2013 | 6 Pages |
Abstract
Our data suggest a valuable diagnostic impact of CTGF in serum for the follow-up of patients suffering from chronic liver diseases developing fibrosis, cirrhosis and finally HCC. CTGF serum levels in HCC are most likely due to underlying fibrosis/cirrhosis but not due to malignancy per se.
Keywords
ECMTGF-βHBcAbHAVTNMHBsAgHBeAgPLTCLDHEVALTCTGFHCCASTAspartate aminotransferaseAlanine aminotransferasealpha-fetoproteinHepatitis B surface antigenAPRichronic liver diseasesBiomarkerTransforming Growth Factor BetaAFPAnti-HCVConnective tissue growth factorLiver fibrosisExtracellular matrixBMPHepatitis B e antigenhepatitis B core antibodyHBVHepatitis C virusHCVhuman immunodeficiency virusHIVhepatitis A virusHepatitis E virushepatitis B virusbone morphogenetic proteinsHepatocellular carcinoma
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Olav A. Gressner, Meng Fang, Hui Li, Lun Gen Lu, Axel M. Gressner, Chun Fang Gao,